Search research articles
Contact Us
Filters
Showing results (41-50 of 44) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 44 results.
Frontiers in Endocrinology
|
November 19, 2025
U-TXM: a novel biomarker for early detection of diabetic kidney disease
Yujie Jin, Jiahao Xu, Yan Ma, et al.
BMC Infectious Diseases
|
April 18, 2015
Characterizing the epidemiology, virology, and clinical features of influenza in China's first severe acute respiratory infection sentinel surveillance system, February 2011-October 2013
Zhibin Peng, Luzhao Feng, Greene M Carolyn, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 19, 2021
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial
Shengxiang Ren, Jianhua Chen, Xingxiang Xu, et al.
Molecular Cancer
|
January 4, 2022
On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial
Tao Jiang, Jianhua Chen, Xingxiang Xu, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 44) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 44 results.
Frontiers in Endocrinology
|
November 19, 2025
U-TXM: a novel biomarker for early detection of diabetic kidney disease
Yujie Jin, Jiahao Xu, Yan Ma, et al.
BMC Infectious Diseases
|
April 18, 2015
Characterizing the epidemiology, virology, and clinical features of influenza in China's first severe acute respiratory infection sentinel surveillance system, February 2011-October 2013
Zhibin Peng, Luzhao Feng, Greene M Carolyn, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 19, 2021
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial
Shengxiang Ren, Jianhua Chen, Xingxiang Xu, et al.
Molecular Cancer
|
January 4, 2022
On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial
Tao Jiang, Jianhua Chen, Xingxiang Xu, et al.
Page
of 5